Welcome to the e-CCO Library!

OP09: Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras – Results from a Western Hungarian Population-based Inception Cohort between 1977–2020
Year: 2023
Source: ECCO’23 Copenhagen
Authors: LakatosPhD, P.L.(1)*;Gonczi, L.(2);Lakatos, L.(3);Golovics, P.A.(4);Pandur, T.(5);David, G.(3);Erdelyi, Z.(3);Szita , I.(3);
Created: Friday, 14 July 2023, 10:43 AM
OP09: Patient reported outcomes reflect histologic disease activity in patients with Ulcerative Colitis: Interim analysis of the APOLLO study
Year: 2021
Source: ECCO'21 Virtual
Authors: Verstockt, B.(1,2,3);Jorissen, C.(1,2);Hoefkens, E.(1);Lembrechts, N.(1);Pouillon, L.(1);Bossuyt, P.(1,2)
Created: Wednesday, 2 June 2021, 4:12 PM
OP09: Proactive Therapeutic Drug Monitoring is superior to standard treatment during maintenance therapy with infliximab; results from a 52-week multicentre randomised trial of 450 patients; the NOR-DRUM B study
Year: 2022
Source: ECCO'22
Authors: Jørgensen, K.K.(1);Syversen, S.W.(2);Goll, G.L.(2); Bjørlykke, K.H.(1,3);Sandanger, Ø.(4);Sexton, J.(2);Brun, M.K.(2,3);Noraberg, G.(5);Ystrøm, C.M.(6); Seeberg, K.A.(7);Blomgren, I.M.(8);Torp, R.(9);Mørk, C.(10);Kvien, T.K.(2,3); Bolstad , N.(4);Haavardsholm, E.A.(2,3);Jahnsen, J.(1,3); The NOR-DRUM study group
Created: Friday, 11 February 2022, 3:52 PM
OP10 IgA coating of intestinal microbiota is associated with inflammatory bowel disease in twin pairs discordant for inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Brand1, Y. Laenen2, F. van Wijk3, M. de Zoete4, B. Oldenburg5, On behalf of the Dutch TWIN-IBD Consortium

Created: Thursday, 30 January 2020, 10:12 AM
OP10: Comparative efficacy of biologics for endoscopic healing of the ileum and colon in Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Narula, N.(1);Wong, E.(1);Dulai, P.(2);Marshall, J.(1);Jairath, V.(3);Reinisch, W.(4);
Created: Friday, 11 February 2022, 3:52 PM
OP10: Proctocolectomy with permanent ileostomy is associated with better transplant-free survival in patients with primary sclerosing cholangitis: a retrospective cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mol, B.(1)*;van Nieuwamerongen, M.(1);van Munster, K.(1);van Munster, S.(1);de Vries, A.(2);van der Meer, A.(2);Goet, J.(2);Weersma, R.(3);Inderson, A.(4);Boonstra, K.(1);van Meer, S.(5);de Boer, Y.(1);Spanier, M.(6);Drenth, J.(7);de Vries, E.(8);Beuers, U.(1);Bogaards, J.(9);Ponsioen, C.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP10: Response to biologics in IBD patients assessed by Computerized image analysis of Probe Based Confocal Laser Endomicroscopy with molecular labeling and gene expression profiling
Year: 2021
Source: ECCO'21 Virtual
Authors: Iacucci, M.(1,2,3);Jeffery, L.(1);Acharjee, A.(4);Nardone, O.M.(1);Smith, S.C.(1);Labarile, N.(1);Zardo, D.(5);Cannatelli, R.(1);Shivaji, U.N.(1);Ungar, B.(1);Buda, A.(6);Grisan, E.(7);Gkoutos, G.(4);Subrata, G.(1,2,3)
Created: Wednesday, 2 June 2021, 4:12 PM
OP10: Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Brooks*1,2, D. Modos3, P. Sudhakar4,5, D. Fazekas4,6, A. Zoufir3, A. Watson1,7, M. Tremelling1, B. Verstockt8, S. Vermeire8, A. Bender3, S. Carding2,7, T. Korcsmaros2,4

Created: Friday, 22 February 2019, 9:41 AM
OP11 Exposure to an inflammatory mix re-induces inflammation in organoids of ulcerative colitis patients, independent of the inflammatory state of the tissue of origin
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Arnauts1,2, B. Verstockt1,3, J. Sabino1,3, S. Vermeire1,3, C. Verfaillie2, M. Ferrante1,3

Created: Thursday, 30 January 2020, 10:12 AM
OP11: Expanded genome-wide association study of Inflammatory Bowel Disease identifies 174 novel loci and directly implicates new genes in disease susceptibility
Year: 2022
Source: ECCO'22
Authors: Fachal, L.(1);the International IBD Genetics Consortium, O.B.O.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP11: Ileocecal resection for recently diagnosed ileocecal Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Agrawal, M.(1,2)*;Ebert, A.(2);Poulsen, G.(2);Ungaro, R.(1);Faye, A.(3);Jess, T.(2,4);Colombel, J.F.(1);Allin, K.(2,4);
Created: Friday, 14 July 2023, 10:43 AM
OP11: Longitudinal profiling of mucosal immune cell composition using multiplex immunohistochemistry identifies drug- and response-specific patterns in Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Volk, V.(1);Aden, K.(2);Tran, F.(2);Mishra, N.(3);Bernardes, J.(3);Röcken, C.(4);Schreiber, S.(2);Feuerhake, F.(1);Rosenstiel, P.(3)
Created: Wednesday, 2 June 2021, 4:12 PM
OP11: Organoids derived from inflamed intestinal biopsies of patients with ulcerative colitis lose their inflammatory phenotype during ex vivo culture
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Arnauts*1,2, B. Verstockt1,3, M. Vancamelbeke1, S. Vermeire1,3, C. Verfaillie2, M. Ferrante1,3

Created: Friday, 22 February 2019, 9:41 AM
OP12 The incidence and disease course of perianal Crohn’s disease: A Danish nationwide cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.D. Wewer1, M. Zhao2, A. Nordholm-Carstensen3, J.B. Seidelin1, J. Burisch2

Created: Thursday, 30 January 2020, 10:12 AM
OP12: Blood proteins related to immunoregulation or cellular junctions reveal distinct biological profiles associated with the risk of short-term versus mid/long-term relapse in Crohn’s Disease patients stopping infliximab
Year: 2021
Source: ECCO'21 Virtual
Authors: Pierre , N.(1);Huynh-Thu , V.A.(2);Allez , M.(3);Bouhnik , Y.(4);Laharie , D.(5);Bourreille , A.(6);Colombel , J.F.(7);Meuwis , M.A.(1);Louis , E.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP12: does early initiation of biologics change the natural history of IBD? a nationwide study from the epi-IIRN
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Focht, G.(1)*;Lujan, R.(1);Atia, O.(1);Greenfeld, S.(2);Kariv, R.(2);Loewenberg Weisband, Y.(3);Lederman, N.(4);Matz, E.(5);Dotan, I.(6);Turner, D.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP12: Segmental vs Total Colectomy for Crohn’s Disease of the colon in the biologic era. Results from the SCOTCH international, multicentric study
Year: 2022
Source: ECCO'22
Authors: PellinoMD- PhD- FRCS- FEBS Coloproctology- FA, G.(1);Rottoli, M.(2);Mineccia, M.(3);Frontali, A.(4);Celentano, V.(5);Colombo, F.(6);Ardizzone, S.(7);Martí, M.(8);Espín-Basany, E.(8);Ferrero, A.(9);Panis, Y.(10);Poggioli, G.(11);Sampietro, G.M.(12);
Created: Friday, 11 February 2022, 3:52 PM
OP12: Targeting inflammation in ulcerative colitis by inhibiting glucose uptake
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Gropp*1, H. Jodeleit1, J. Caesar1, C. Villarroel Aguilera1, F. Beigel2,3, S. Breiteneicher3, J. Stallhofer3, M. Siebeck1

Created: Friday, 22 February 2019, 9:41 AM
OP13 Glyco-fingerprint as a relevant risk factor on colitis-associated cancer
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Dias1, E. Gomes1, M. Silva1, Â. Fernandes1, M. Garrido2, R. Marcos-Pinto2, P. Lago2, S. Pinho1

Created: Thursday, 30 January 2020, 10:12 AM
OP13: Modified 2-stage vs. 3-stage ileal pouch-anal anastomosis result in equivalent long-term functional outcomes and pouch survival: A matched-pair analysis
Year: 2022
Source: ECCO'22
Authors: HolubarMD- MS, S.(1);Prien, C.(1);Jia, X.(2);Liska, D.(1);Kessler, H.(1);Valente, M.(1);Lightner, A.(1);Gorgun, E.(1);Hull, T.(1);Steele, S.(1);
Created: Friday, 11 February 2022, 3:52 PM